TY - JOUR ID - 9963 TI - Administration of melatonin protects against acetylsalicylic acid-induced impairment of male reproductive function in mice JO - Iranian Journal of Basic Medical Sciences JA - IJBMS LA - en SN - 2008-3866 AU - Hedayati Emami, Niloufar AU - Mahmoudi lafout, Farzaneh AU - Mohammadghasemi, Fahimeh AD - Student Research Center, Guilan University of Medical Sciences, Rasht-Iran AD - Anatomy Department, Faculty of Medicine, Guilan University of Medical Sciences, Rasht-Iran AD - Cellular & Molecular Research Center, Faculty of Medicine, Guilan University of Medical Sciences, Rasht-Iran Y1 - 2018 PY - 2018 VL - 21 IS - 2 SP - 124 EP - 129 KW - Acetylsalicylic acid KW - Antioxidants KW - Epididymis KW - Melatonin KW - Sperm KW - Testosterone DO - 10.22038/ijbms.2017.23833.5989 N2 - Objective(s): Melatonin, an important hormone secreted by the epiphysis, is a powerful anti-oxidant with a high potential to neutralize medical toxins. The goal of this study was to demonstrate the beneficial effect of melatonin on epididymal sperm and reproductive parameters in mice treated with acetylsalicylic acid (ASA). Materials and Methods: Male adult mice were divided into four treatment groups: control, ASA, melatonin, and ASA+melatonin. Mice were administered ASA (50 mg/kg, orally) and/or melatonin (10 mg/kg, intraperitoneally), or vehicle control, for 14 days. Sperm count, sperm motility, and sperm morphology were evaluated to assess fertility. A colorimetric assay was used to measure serum total antioxidant capacity (TAC). A sperm chromatin dispersion (SCD) test was used to assess sperm chromatin integrity. Sex hormone levels were measured by ELISA. Results: Compared to the control group, ASA treatment resulted in a significant decrease in sperm parameters (P<0.05), as well as a decrease in the integrity of sperm chromatin (P<0.01). ASA treatment also reduced serum testosterone and TAC levels (P<0.05). Co-administration of melatonin with ASA significantly improved epididymal sperm parameters and increased serum testosterone and TAC levels compared to the ASA-treated group. LH level was not different in the combined treatment group compared to control or ASA treatment. Conclusion: Short-term administration of ASA (50 mg/kg) has adverse effects on male reproductive function in mice. Co-administration of melatonin protects against ASA-induced impairment of male reproductive function by preventing the reduction in serum TAC and testosterone levels seen with ASA treatment alone. UR - https://ijbms.mums.ac.ir/article_9963.html L1 - https://ijbms.mums.ac.ir/article_9963_d26dbf996ad73e7c8bbaa8aa0e1a0d4a.pdf ER -